Effect of metabolic syndrome on incidence of oral potentially malignant disorder: A prospective cohort study in Taiwan

Pallop Siewchaisakul, Sen Te Wang, Szu Min Peng, Pongdech Sarakarn, Li Sheng Chen, Tony Hsiu Hsi Chen, Yen Po Yeh, Amy Ming Fang Yen

研究成果: 雜誌貢獻文章同行評審

1 引文 斯高帕斯(Scopus)

摘要

Objectives We aimed to assess the effect of metabolic syndrome (MetS) on incident oral potentially malignant disorder (OPMD). Design We conducted a prospective cohort study of the Changhua community-based integrated screening (CHCIS) programme and nationwide oral cancer screening programme during the period between 2005 and 2014. Setting CHCIS, Taiwan. Participants We enrolled 17 590 participants aged 30 years and older. Main outcomes and measures We assessed the impact of MetS on the outcome measured by incident OPMD. Results The incidences of OPMD among subjects with and without MetS were 7.68 ‰ and 5.38 ‰, respectively. After adjusting for confounders, subjects with MetS exhibited a statistically greater risk of developing OPMD compared with those who were free of MetS by 33% (adjusted rate ratio, aRR=1.33, 95% CI 1.14 to 1.55). Individual components of MetS still remained significant, including central obesity (aRR=1.22, 95% CI 1.04 to 1.44), hypertriglyceridaemia (aRR=1.26, 95% CI 1.07 to 1.49) and hyperglycaemia (aRR=1.20, 95% CI 1.02 to 1.41). Central obesity and hypertriglyceridaemia were also statistically associated with a subtype of OPMD, namely, leukoplakia. Conclusion The temporal influence of MetS on the risk of incident OPMD was noted in our prospective cohort study. Therefore, promoting an MetS prevention and control programme might reduce the occurrence of OPMD and oral cancer.
原文英語
文章編號e041971
期刊BMJ Open
10
發行號10
DOIs
出版狀態已發佈 - 十月 14 2020

ASJC Scopus subject areas

  • 醫藥 (全部)

指紋

深入研究「Effect of metabolic syndrome on incidence of oral potentially malignant disorder: A prospective cohort study in Taiwan」主題。共同形成了獨特的指紋。

引用此